282 related articles for article (PubMed ID: 21721205)
1. [Management of anal canal carcinoma].
Thang NN; Cochet S; George AC; Betz M; Roth A
Rev Med Suisse; 2011 May; 7(296):1144-8. PubMed ID: 21721205
[TBL] [Abstract][Full Text] [Related]
2. Treatment of epidermoid carcinoma of the anal canal.
Greenall MJ; Quan SH; Urmacher C; DeCosse JJ
Surg Gynecol Obstet; 1985 Dec; 161(6):509-17. PubMed ID: 3934775
[TBL] [Abstract][Full Text] [Related]
3. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
[TBL] [Abstract][Full Text] [Related]
4. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.
Wexler A; Berson AM; Goldstone SE; Waltzman R; Penzer J; Maisonet OG; McDermott B; Rescigno J
Dis Colon Rectum; 2008 Jan; 51(1):73-81. PubMed ID: 18066626
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy for epidermoid carcinoma of the anus: thirty years' experience.
Myerson RJ; Outlaw ED; Chang A; Birnbaum EH; Fleshman JW; Grigsby PW; Kodner IJ; Malayapa RS; Mutch MG; Parikh P; Picus J; Tan BR
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):428-35. PubMed ID: 19251377
[TBL] [Abstract][Full Text] [Related]
6. [Three cases of radiotherapy combined with S-1 and mitomycin C for anal canal squamous cell carcinomas].
Shiozawa M; Nishimura K; Nonaka T; Yoshii T; Nakayama N; Motohashi O; Takagi S; Nakayama Y; Akaike M
Gan To Kagaku Ryoho; 2010 Dec; 37(13):2941-3. PubMed ID: 21160276
[TBL] [Abstract][Full Text] [Related]
7. Management of anal cancer in the HIV-positive population.
Kauh J; Koshy M; Gunthel C; Joyner MM; Landry J; Thomas CR
Oncology (Williston Park); 2005 Nov; 19(12):1634-8; discussion 1638-40, 1645 passim. PubMed ID: 16396154
[TBL] [Abstract][Full Text] [Related]
8. Carcinoma of the anal canal: small steps in treatment advances.
Eng C
Clin Adv Hematol Oncol; 2011 Sep; 9(9):662-9. PubMed ID: 22402509
[TBL] [Abstract][Full Text] [Related]
9. HIV-associated anal squamous cell cancer: an otherwise preventable disease.
Konstantinopoulos PA; Schlecht HP; Bryan B; Pantanowitz L; Dezube BJ
J Clin Oncol; 2006 Sep; 24(27):4516-7. PubMed ID: 16983122
[No Abstract] [Full Text] [Related]
10. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome.
Roohipour R; Patil S; Goodman KA; Minsky BD; Wong WD; Guillem JG; Paty PB; Weiser MR; Neuman HB; Shia J; Schrag D; Temple LK
Dis Colon Rectum; 2008 Feb; 51(2):147-53. PubMed ID: 18180997
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and toxicity of chemoradiation in the treatment of HIV-associated anal cancer.
Hauerstock D; Ennis RD; Grossbard M; Evans A
Clin Colorectal Cancer; 2010 Oct; 9(4):238-42. PubMed ID: 20920996
[TBL] [Abstract][Full Text] [Related]
12. Recurrent squamous cell carcinoma of the anal canal. Predictors of initial treatment failure and results of salvage therapy.
Longo WE; Vernava AM; Wade TP; Coplin MA; Virgo KS; Johnson FE
Ann Surg; 1994 Jul; 220(1):40-9. PubMed ID: 8024357
[TBL] [Abstract][Full Text] [Related]
13. Review of anal cancer patients at the Ottawa hospital.
Abunassar M; Reinders J; Jonker DJ; Asmis T
Eur J Surg Oncol; 2015 May; 41(5):653-8. PubMed ID: 25776438
[TBL] [Abstract][Full Text] [Related]
14. [A case of squamous cell carcinoma of the anal cancer with associated human immunodeficiency virus].
Sueda K; Ikenaga M; Miyazaki M; Yasui M; Mishima H; Tsujie M; Omiya H; Miyamoto A; Hirao M; Takami K; Fujitani K; Nakamori S; Yoshida K; Tsujinaka T
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2656-8. PubMed ID: 21224670
[TBL] [Abstract][Full Text] [Related]
15. Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.
Grabenbauer GG; Kessler H; Matzel KE; Sauer R; Hohenberger W; Schneider IH
Dis Colon Rectum; 2005 Sep; 48(9):1742-51. PubMed ID: 15991058
[TBL] [Abstract][Full Text] [Related]
16. [Cancer of the anal canal].
Ruíz Molina JM; Gómez Aceytuno R; Gallardo Rincón D; Herrera R; Mondragón Sánchez RJ; Oñate Ocaña LF; Aiello Crocifoglio V
Rev Gastroenterol Mex; 1997; 62(3):184-8. PubMed ID: 9480525
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
[TBL] [Abstract][Full Text] [Related]
18. [Squamous cell carcinoma of the canal anal].
Guimarães AP; Matos D; Segreto R; Forones NM
Arq Gastroenterol; 2001; 38(1):9-13. PubMed ID: 11582966
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.
Hung A; Crane C; Delclos M; Ballo M; Ajani J; Lin E; Feig B; Skibber J; Janjan N
Cancer; 2003 Mar; 97(5):1195-202. PubMed ID: 12599225
[TBL] [Abstract][Full Text] [Related]
20. [Anal canal squamous-cell carcinomas in HIV positive patients: clinical features, treatments and prognosis].
Vatra B; Sobhani I; Aparicio T; Girard PM; Puy Montbrun TD; Housset M; Baillet F; Hecht F; Chossidow D; Soulé JC
Gastroenterol Clin Biol; 2002 Feb; 26(2):150-6. PubMed ID: 11938066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]